Theorem Clinical Research Appoints Bollwage as Vice President of Global Regulatory Affairs

(King of Prussia, PA; January 17, 2012) –Theorem Clinical Research, a full-service contract research organization (CRO) that provides core clinical research and development services, is pleased to announce the appointment of Brian Bollwage, J.D., as Vice President of Global Regulatory Affairs.

Bollwage previously served as Director of Global Regulatory Science at Bristol-Myers Squibb and as Executive Director and Regulatory Counsel of Global Regulatory Intelligence at i3 Research.

“Brian brings a wealth of global regulatory leadership experience in both the CRO and pharmaceutical industries,” stated Theorem Clinical Research Chief Executive Officer John Potthoff. “I am certain that he will excel in his new role.”

Bollwage is a food and drug law expert with published articles in Regulatory Affairs Focus, PharmaVOICE and Applied Clinical Trials, among others. A graduate of Rutgers Law School, he currently serves as an associate professor of food and drug law at Temple University in Philadelphia. Bollwage also holds a Master of Business Administration, specializing in pharmaceutical/chemical studies, and a Master of Science.

Established in 1985, Theorem Clinical Research is one of the industry’s leading full-service, contract research organizations (CRO). A global organization with 1,000+ employees located throughout 27 countries, Theorem Clinical Research provides core clinical research and development services including statistics, data management and biostatistics for the pharmaceutical, biotech and medical device industries. Theorem Clinical Research manages complex therapeutic studies with speed, flexibility and attention to detail to drive a high-quality performance.

About Theorem Clinical Research

Theorem Clinical Research is one of the industry’s leading full-service, contract research organizations (CRO). Before launching in 2011, Theorem Clinical Research operated for nearly two decades as Omnicare Clinical Research under the Omnicare Inc. parent company. A global organization with 1,000+ employees located throughout 27 countries, Theorem Clinical Research provides core CRO services for Phases I-IV, but with niche business units in the areas of technical services, medical devices and pharmaceutics with speed, flexibility and attention to detail to drive a high-quality performance. For more information, visit www.theoremclinical.com.

MORE ON THIS TOPIC